Literature DB >> 28617942

Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17+ RORγt+ /IL-10+ FoxP3+ ratio.

Y Su1,2, Q Wang3, B Yang1, L Wu1, G Cheng2, H Kuang1.   

Abstract

Datura metel L. is a medicinal herb that contains withasteroids and has a wide range of biological activities. We isolated seven withasteroids from the flowers of D. metel L and examined their ability to inhibit immune responses in vitro and in vivo. Among the withasteroids, withasteroid B2 exhibited the strongest inhibitory effect on immune responses comparing B2 with other isolated compounds from D. metel L., including suppressing the differentiation of CD4+ T cells by inhibiting the expression and production of T cell lineage-specific master regulators and cytokines and directly suppressing the cytokine-induced Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathways. In the interleukin (IL)-23-induced mouse ear model of skin disease, B2 repressed disease development by inhibiting the expression of proinflammatory mediators in murine ear skin. Moreover, B2 affected the maturation of dendritic cells (DCs) in vitro which, in turn, induced T cell differentiation with an increased regulatory T cell (Treg ) phenotype and decreased T helper type 17 (Th17) phenotype. This study provides new evidence that B2 might ameliorate chronic inflammatory skin diseases by suppressing pathogenic CD4+ T cell differentiation and the IL-17+ retinoic-acid-receptor-related orphan receptor gamma t (RORγt)+ /IL-10+ forkhead box protein 3 (FoxP3)+ ratio. These findings suggest that B2 might mediate the therapeutic effects observed in psoriasis patients following treatment with D. metel L.
© 2017 British Society for Immunology.

Entities:  

Keywords:  IL-17+RORγt+/IL-10+FoxP3+ ratio; JAK/STAT pathways; autoimmune disease

Mesh:

Substances:

Year:  2017        PMID: 28617942      PMCID: PMC5588778          DOI: 10.1111/cei.12998

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

2.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

3.  Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.

Authors:  Ken Miyoshi; Mikiro Takaishi; Kimiko Nakajima; Mitsunori Ikeda; Takashi Kanda; Masahito Tarutani; Tatsuo Iiyama; Naoki Asao; John DiGiovanni; Shigetoshi Sano
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

Review 4.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 5.  Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.

Authors:  Jinfang Zhu; William E Paul
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

Review 6.  The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

Authors:  David A Martin; Jennifer E Towne; Gregory Kricorian; Paul Klekotka; Johann E Gudjonsson; James G Krueger; Chris B Russell
Journal:  J Invest Dermatol       Date:  2012-06-07       Impact factor: 8.551

Review 7.  Interleukin-17 in inflammatory skin disorders.

Authors:  Astrid J van Beelen; Marcel B M Teunissen; Martien L Kapsenberg; Esther C de Jong
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-10

8.  Circulating Th17, Th22, and Th1 cells are increased in psoriasis.

Authors:  Shinji Kagami; Heather L Rizzo; Jennifer J Lee; Yoshinobu Koguchi; Andrew Blauvelt
Journal:  J Invest Dermatol       Date:  2009-12-24       Impact factor: 8.551

9.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  Two new withanolide lactones from flos daturae.

Authors:  Hai-Xue Kuang; Bing-You Yang; Yong-Gang Xia; Qiu-Hong Wang
Journal:  Molecules       Date:  2011-07-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.